TXG

NASDAQ · Life Sciences Tools & Services

10X Genomics Inc-Class A

Mid-Cap Stocks Healthcare Stocks

$34.76

+2.63 (+8.17%)

As of Jun 21, 10:01 PM ET ·

TXG News1 articles

10x Genomics Tumbles on Revenue Slide; Buffett Warns of 'Gambling Mood'

10x Genomics shares dropped 5.3% after Q1 revenue fell 2.6% year-over-year, while Warren Buffett cautioned investors against a 'gambling mood' driving unsustainable valuations.